2
results found
Objective To investigates the role of serum interleukin-6 (IL-6) and tumor necrosis factor-α(TNF-α) levels as prognostic biomarkers in patients receiving First-Line Platinum-Based Chemotherapy Combine...
Non-small cell lung cancer
Immunotherapy
platinum-based chemotherapy
Efficacy prediction
Interleukin-6
Tumor necrosis factor-α
Background: Accurately predicting treatment outcomes in patients with advanced non-small cell lung cancer (NSCLC) remains a significant clinical challenge. While circulating tumor DNA (ctDNA) within p...
Liquid biopsy monitoring
Cell-free DNA
Non-small cell lung cancer
Progression-free survival
Copy-number alterations
cfDNA fragmentation
Low-coverage whole-genome sequencing
SinoXiv